Evidence map›Paper›PMID 28348868›Full record

ArticleMicrobial genomics2016

The diversity of

Rainer Follador, Eva Heinz, Kelly L Wyres, Matthew J Ellington, Michael Kowarik, Kathryn E Holt, Nicholas R Thomson

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 214 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 1 synthesis or guideline pooled it, 328 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Manipulation of Host Cells byInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Hypermucoviscosity inJournal of bacteriology · 2026
    Review
  6. mBio · 2026
    Article
  7. Article
  8. Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Materials today. Bio · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Modular Development of aNanomaterials (Basel, Switzerland) · 2026
    Article
  17. Longitudinal genomic insights into resistance and virulence dynamics of Klebsiella pneumoniae clinical isolates from Pakistan.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  18. Review
  19. Emergence of Carbapenem-Resistant Hypervirulent ST111 K63Polish journal of microbiology · 2026
    Article
  20. Article

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rainer Follador1​LimmaTech Biologics AG, Schlieren, Switzerland.
Eva Heinz2​The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Kelly L Wyres3​Centre for Systems Genomics, University of Melbourne, Parkville, Victoria, Australia.
Matthew J Ellington5​National Infection Service Public Health England, London, UK.
Michael Kowarik1​LimmaTech Biologics AG, Schlieren, Switzerland.
Kathryn E Holt3​Centre for Systems Genomics, University of Melbourne, Parkville, Victoria, Australia.
Nicholas R Thomson2​The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
University of Melbourne · AUWellcome Sanger Institute · GBPublic Health England · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic VariationAntigens, BacterialAntigens, SurfaceHumansKlebsiella pneumoniaeO AntigensPhylogenySeroepidemiologic StudiesSerogroupVirulenceAntigens, BacterialAntigens, SurfaceK antigensO AntigensK antigen and O antigenKlebsiella pneumoniaeseroepidemiologysurface polysaccharidevaccine target

Identifiers

PMID28348868
PMCPMC5320592
OpenAlexW2412176113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.